ScienceDirect - Gynecologic Oncology : A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group
Links shared publicly online about this topic.
- 254total visits
ScienceDirect - Gynecologic Oncology : A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group
ScienceDirect - Gynecologic Oncology : A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study
View full resource at sciencedirect.com
Tags: Cancer, Cancer Medication, Ovarian Cancer, Women's Health, Taxol, Oncology
Most Recently Shared on May 31, 2011 at 4:15 am By:
GOG ph. 2 study: M.D. Anderson finds wkly nab-paclitaxel has clinical efficacy in resistant/refractory ovarian cancer. http://dld.bz/abFcJ
Advertisement
